Chongqing Zhifei Biological Products Co., Ltd. Stock: price and insider trades · China

智飞生物

Chongqing Zhifei Biological Products Co., Ltd.: what insiders have been doing

We have very little insider data for Chongqing Zhifei Biological Products Co., Ltd. so far: the most recent filing dates from 14 March 2022. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.

Key facts

Headquarters: People's Republic of China

Source: Wikidata (CC0).

Insider Decl.

Thresholds

n/a

Buy Volume

n/a

Sell Volume

€187M

1 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score

Ranked 22,877 of 26,897 companies

26.5

score / 100

Value

Quality

FCF yld15%

Earn yld-49%

EV/EBITDA·

ROE-66%

Gross mgn7.8%

Net mgn·

Debt/EBITDA·

Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥12.48

Analyst consensus

3 analysts

2.33/5

CN¥12.20Target CN¥15.40(+23%)CN¥18.00

Income statement

RevenueCN¥9B

Gross profitCN¥702.7M8% margin

EBITDA-CN¥16.6B-186% margin

Net income-CN¥14.7B-185.3% margin

Valuation

PER (forward)-29.7x

P/Book2.0x

Beta0.44

Balance sheet & cash

Market capCN¥29.9B

Total debtCN¥12.3B

Free Cash FlowCN¥4.5B

Debt / Equity67%

Profitability & ownership

ROE-65.7%

ROA-29.4%

% insiders58.6%

% institutions8.0%

Last declaration on 14 March 2022

Declarations1 total

▼
蒋仁生
董事,高管Executives14 Mar 2022
1B CNY15SZSE
12,980,000 shares100.0% of flowA股XSHESZSE:173000005358671230

1 of 1 declaration

About Chongqing Zhifei Biological Products Co., Ltd.

智飞生物 is a company focused on the health and pharmaceutical sector, specializing in the development and production of vaccines. It is listed on the XSHE market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations